Federated Hermes’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-869,327
| Closed | -$14.3M | – | 2182 |
|
|
2023
Q4 | $14.3M | Hold |
869,327
| – | – | 0.04% | 472 |
|
|
2023
Q3 | $6.72M | Buy |
869,327
+361,105
| +71% | +$1.96M | 0.02% | 628 |
|
|
2023
Q2 | $2.65M | Sell |
508,222
-1,417,155
| -74% | -$7.22M | 0.01% | 867 |
|
|
2023
Q1 | $10.3M | Buy |
1,925,377
+1,085,208
| +129% | +$5.9M | 0.03% | 537 |
|
|
2022
Q4 | $3.12M | Hold |
840,169
| – | – | 0.01% | 793 |
|
|
2022
Q3 | $4.2M | Buy |
840,169
+9,183
| +1% | +$51.1K | 0.01% | 706 |
|
|
2022
Q2 | $4.85M | Hold |
830,986
| – | – | 0.01% | 686 |
|
|
2022
Q1 | $5.92M | Hold |
830,986
| – | – | 0.01% | 735 |
|
|
2021
Q4 | $11M | Buy |
830,986
+237,295
| +40% | +$3.92M | 0.02% | 619 |
|
|
2021
Q3 | $13.7M | Buy |
593,691
+326,911
| +123% | +$9.73M | 0.03% | 567 |
|
|
2021
Q2 | $11.7M | Hold |
266,780
| – | – | 0.02% | 608 |
|
|
2021
Q1 | $19.4M | Hold |
266,780
| – | – | 0.04% | 511 |
|
|
2020
Q4 | $11.5M | Buy |
266,780
+16,780
| +7% | +$751K | 0.02% | 606 |
|
|
2020
Q3 | $10.3M | Sell |
250,000
-18,150
| -7% | -$938K | 0.02% | 565 |
|
|
2020
Q2 | $16.1M | Buy |
268,150
+43,150
| +19% | +$3.95M | 0.04% | 434 |
|
|
2020
Q1 | $16.9M | Hold |
225,000
| – | – | 0.05% | 372 |
|
|
2019
Q4 | $30.9M | Buy |
225,000
+120,000
| +114% | +$14.6M | 0.07% | 309 |
|
|
2019
Q3 | $12.5M | Buy |
+105,000
| New | +$14.7M | 0.03% | 495 |
|
Federated Hermes's ORTX Position: Q1 2024 in Review
Federated Hermes sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 869,327 shares — an estimated $14.3M sold.
Federated Hermes first reported a position in ORTX in Q3 2019 and held it in 18 quarters. The position peaked at $30.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.
- Federated Hermes reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
- Federated Hermes sold 869,327 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $14.3M.
- Federated Hermes first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 18 quarters.
- Federated Hermes's Orchard Therapeutics plc American Depositary Shares position peaked at $30.9M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.